These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32509616)

  • 21. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
    Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonmigrant children with visceral leishmaniasis from the nonendemic area of Uttarakhand.
    Mathur SB; Arya AK
    J Trop Pediatr; 2014 Aug; 60(4):322-5. PubMed ID: 24531375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemophagocytic lymphohistiocytosis secondary to visceral leishmaniasis in an endemic area in the north of Minas Gerais, Brazil.
    Carvalho FHG; Lula JF; Teles LF; Caldeira AP; Carvalho SFG
    Rev Soc Bras Med Trop; 2020; 53():e20190491. PubMed ID: 32578702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visceral leishmaniasis from a non-endemic Himalayan region of Nepal.
    Shrestha M; Pandey BD; Maharjan J; Dumre SP; Tiwari PN; Manandhar KD; Pun SB; Pandey K
    Parasitol Res; 2018 Jul; 117(7):2323-2326. PubMed ID: 29717371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral Leishmaniasis in Sub-Himalayan India (1967-2023): A Systematic Review.
    Mewara A; Satapathy P; Dhatwalia SK
    Am J Trop Med Hyg; 2024 Nov; 111(5):928-933. PubMed ID: 39191237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India.
    Kumar Bhat N; Ahuja V; Dhar M; Ahmad S; Pandita N; Gupta V; Chandra S
    J Trop Pediatr; 2017 Apr; 63(2):104-108. PubMed ID: 27582128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Lima MA; Mitra G; Verma N; Balasegaram M; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2603. PubMed ID: 24392168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area.
    Bode SF; Bogdan C; Beutel K; Behnisch W; Greiner J; Henning S; Jorch N; Jankofsky M; Jakob M; Schmid I; Veelken N; Vraetz T; Janka G; Ehl S; Lehmberg K
    J Pediatr; 2014 Jul; 165(1):147-153.e1. PubMed ID: 24797953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Presentation of Leishmaniasis.
    Prajapati R; Kumar A; Sharma P; Singla V; Bansal N; Dhawan S; Arora A
    J Clin Exp Hepatol; 2016 Jun; 6(2):146-8. PubMed ID: 27493461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and laboratory characteristics of hemophagocytic lymphohistiocytosis induced by Leishmania infantum infection.
    Shi Q; Huang M; Li X; Zheng X; Wang F; Zou Y; Wang L; Jia J
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009944. PubMed ID: 34735436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.
    Malek MS; Robi IH; Islam MS; Kabir MA; Uddin MZ; Sumon SM; Siddiqui NI
    Mymensingh Med J; 2020 Oct; 29(4):879-886. PubMed ID: 33116091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic Strategies.
    Dondi A; Manieri E; Gambuti G; Varani S; Campoli C; Zama D; Pierantoni L; Baldazzi M; Prete A; Attard L; Lanari M; Melchionda F
    Healthcare (Basel); 2023 Dec; 12(1):. PubMed ID: 38200929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemophagocytic Syndrome in Children With Visceral Leishmaniasis.
    Daher EF; Lima LL; Vieira AP; Nascimento LS; Soares DS; Abreu KL; Zuntini KL; Silva Junior GB
    Pediatr Infect Dis J; 2015 Dec; 34(12):1311-4. PubMed ID: 26780020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.
    Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D
    Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Laboratory Analysis of Patients with Leishmaniasis: A Retrospective Study from a Tertiary Care Center in New Delhi.
    Gupta N; Kant K; Mirdha BR
    Iran J Parasitol; 2017; 12(4):632-637. PubMed ID: 29317889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An adult case of visceral leishmaniasis in a province of Black-Sea region, Turkey].
    Oztoprak N; Aydemir H; Pişkin N; Seremet Keskin A; Araslı M; Gökmen A; Celebi G; Külekçi Uğur A; Taylan Özkan A
    Mikrobiyol Bul; 2010 Oct; 44(4):671-7. PubMed ID: 21063981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece.
    Georgiadou SP; Stefos A; Spanakos G; Skrimpas S; Makaritsis K; Sipsas NV; Dalekos GN
    Int J Infect Dis; 2015 May; 34():46-50. PubMed ID: 25743761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.